Physician profile
Anthony Robinson
NPI 1558559633
$1,954.43
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $751 · 2022: $513 · 2023: $491 · 2024: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $485.84 | 2021-2024 | Belbuca, Xtampza |
| Medtronic, INC. | $346.03 | 2021-2023 | Intellis Adaptivestim |
| Teva Pharmaceuticals USA, INC. | $151.05 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $128.20 | 2023 | |
| Vanda Pharmaceuticals INC. | $119.92 | 2024 | Fanapt |
| Janssen Pharmaceuticals, INC | $114.55 | 2023 | Invega Sustenna |
| Si-Bone, INC. | $89.95 | 2022 | |
| Biodelivery Sciences International, INC. | $83.74 | 2021 | |
| Arbor Pharmaceuticals, INC. | $83.51 | 2021-2022 | |
| Grt US Holding, INC. | $53.79 | 2022 | |
| Horizon Therapeutics Plc | $46.49 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $45.61 | 2021-2022 | |
| Abbott Laboratories | $40.38 | 2024 | Eterna |
| Nalu Medical, INC. | $34.93 | 2023 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.99 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $29.23 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.11 | 2022 | |
| Nevro Corp. | $19.59 | 2024 | Senza |
| Novartis Pharmaceuticals Corporation | $17.64 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.